Company Profile
Creative Medical Technology Holdings Stock Price, News & Analysis
- Ticker:
- CELZ
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
1.15 USD (+71.95%)
Close
Last updated: August 6, 2026
8.24M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, CELZ closed up 71.9% at $1.15. No new same-company headline was identified in the current news window.
Company overview
Business overview
Creative Medical Technology Holdings is a regenerative medicine company focused on cell-based and biologic approaches to difficult diseases. Its story is built around early-stage platform science and the possibility of translating regenerative concepts into practical therapies.
Geographic Base and Sector Classification
Creative Medical Technology is headquartered in the United States and listed on NASDAQ. It sits in regenerative medicine and small-cap biotech rather than commercial pharma.
Business Model Characteristics
The company depends on preclinical and early clinical validation, platform credibility, and capital support. Investors typically watch scientific updates, financing, and whether the company can narrow its story into a viable development path.
Position Within the Biotechnology Landscape
Creative Medical Technology occupies a speculative regenerative-medicine niche within biotech. It tends to trade on platform promise more than on near-term commercial visibility.
Future catalysts
Creative Medical’s catalysts are regenerative-medicine and immunotherapy programs, plus any update that shows the company can still create a path forward. The stock remains very much proof-of-concept driven.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Creative Medical Technology Holdings (CELZ)?
Creative Medical Technology Holdings (CELZ) most recently closed at 1.15 USD, a +71.95% move versus the previous session.
What is the market cap of Creative Medical Technology Holdings (CELZ)?
Creative Medical Technology Holdings currently has a market capitalization of 8.24M USD on BioPharmSignal.
What does Creative Medical Technology Holdings do?
Creative Medical Technology Holdings is a regenerative medicine company focused on cell-based and biologic approaches to difficult diseases. Its story is built around early-stage platform science and the possibility of translating regenerative concepts into practical therapies.
On which exchange is CELZ stock listed?
Creative Medical Technology Holdings (CELZ) is associated with NASDAQ, United States, Biopharma.
What is proof-of-concept?
The stock remains very much proof-of-concept driven.
Which conditions is Creative Medical Technology Holdings targeting with proof-of-concept?
The stock remains very much proof-of-concept driven.
How does Creative Medical Technology Holdings describe recent progress with proof-of-concept?
The stock remains very much proof-of-concept driven.
What is Creative?
Creative Medical Technology Holdings is a regenerative medicine company focused on cell-based and biologic approaches to difficult diseases.